Related Experiment Video
Updated: Feb 13, 2026
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
Published on: September 6, 2024
Protein Tyrosine Phosphatase as Potential Therapeutic Target in various Disorders
Shivani Verma1, Saurabh Sharma2
1Department of Pharmacology, Indo-Soviet Friendship Pharmacy College (ISFCP), Moga, Punjab, India.
Background:
Tyrosine-protein phosphatase is an enzyme that functions in a unit with tyrosine kinases to regulate signaling pathways. Several members of the PTP family link to human disease predisposition such as PTP1B, SH2, DEP1, and inhibition of these enzymes may represent an effective palliative therapy.
Objective:
This review aims to summarize the rapidly developing role of the PTPs in various physiological and pathological states.
Results:
Pharmacological inhibition of protein tyrosine phosphatase has been found to reduce endothelial dysfunction in different cardiovascular diseases related to metabolic disorders and it can be helpful for the management of other brain disorders associated with perhaps even in normal, agerelated cognitive decline. Tyrosine-protein phosphates have both stimulatory and inhibitory consequences on cancer-associated signaling pathways and deregulation of PTKs involves tumorgenesis.
Conclusion:
Inhibition of protein tyrosine phosphatase plays an important function in the improvement of various diseases such as metabolic, cardiovascular disorders, cancer and autoimmune disease.
Insights
Protein tyrosine phosphatases (PTPs) regulate signaling pathways and their inhibition shows therapeutic potential. Targeting PTPs may improve metabolic, cardiovascular, and brain disorders, and cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Tyrosine-protein phosphatases (PTPs) are enzymes that work with tyrosine kinases to control cell signaling.
- Dysregulation of PTPs is implicated in various human diseases, including cancer and metabolic disorders.
- Specific PTP family members, such as PTP1B, SH2, and DEP1, are linked to disease predisposition.
Purpose of the Study:
- To review the evolving role of PTPs in physiological and pathological conditions.
- To highlight the therapeutic potential of PTP inhibition across diverse diseases.
Main Methods:
- Literature review of PTP function and therapeutic targeting.
- Analysis of PTP involvement in signaling pathways related to disease.
Main Results:
- Pharmacological inhibition of PTPs can mitigate endothelial dysfunction in cardiovascular diseases linked to metabolic disorders.
- PTPs influence cancer signaling pathways, and their deregulation contributes to tumorigenesis.
- PTP inhibition may offer benefits for brain disorders and age-related cognitive decline.
Conclusions:
- Inhibition of PTPs is a promising therapeutic strategy for a range of diseases.
- PTP modulation is crucial for managing metabolic, cardiovascular, cancer, and autoimmune diseases.
Related Concept Videos
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
02:18Intrinsically Disordered Proteins
02:18Intrinsically Disordered Proteins
01:26Receptor Tyrosine Kinases
01:21The Resting Membrane Potential